Examination of commercial prothrombin-complex (PPSB) preparations for activated factors
Eggeling, B.; Lechler, E.; Asbeck, F.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1140-1144
1975
ISSN/ISBN: 0070-4067 PMID: 1229418 Document Number: 83904
Document emailed within 1 workday
Related Documents
Pansatiankul, B.; Jitapunkul, S. 2008: Risk factors of acquired prothrombin complex deficiency syndrome: a case-control study Journal of the Medical Association of Thailand 91(Suppl 3): S1-S8Alving, B.M.; Tankersley, D.L.; Mason, B.L.; Rossi, F.; Aronson, D.L.; Finlayson, J.S. 1980: Contact-activated factors: contaminants of immunoglobulins preparations with coagulant and vasoactive properties Journal of Laboratory and Clinical Medicine 96(2): 334-346
Takeda, Y. 1970: Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system Journal of Laboratory and Clinical Medicine 75(3): 355-381
Ono, M.; Ohta, H.; Ohhira, M.; Sekiya, C.; Namiki, M. 1990: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma American Journal of Gastroenterology 85(9): 1149-1154
Liapina, L.A.; Strukova, S.M.; Kudriashov, B.A. 1979: Formation of a heparin-prothrombin complex Voprosy Meditsinskoi Khimii 25(1): 41-46
Vlcková, M. 1983: Preparation of a prothrombin complex concentrate for clinical use Vnitrni Lekarstvi 29(6): 579-587
Girolami, A. 1971: Prothrombin complex: new data of biochemical and clinical interest Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 7(1): 449-461
Firoz, M.; Graber, M. 2001: Bioavailability of US commercial magnesium preparations Magnesium Research 14(4): 257-262
Blatt, P.M.; Pearsall, A.H.; Givhan, E.G.; Hallum, C.E.; Roberts, H.R.; Webster, W.P. 1980: Haemostatic failure of prothrombin complex concentrates during elective dental procedure Thrombosis and Haemostasis 42(5): 1604-1606
Keshgegian, A.A.; Mann, J.M.; Cooper, J.H. 1986: Is duplicate testing for prothrombin time and activated partial thromboplastin time necessary? Archives of Pathology and Laboratory Medicine 110(6): 520-522
Langer, B.; Fuess, V.L.; Kauffman, P.; Bechara, M.J.; dos Reis, J.M.; Kwang, W.T. 1984: Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K Revista do Hospital das Clinicas 39(1): 18-22
O'Neill, P.A.; Woodson, D.L.; Mackler, B.F. 1978: EAC rosette-forming lymphocytes in commercial preparations of sheep erythrocytes Journal of Immunology 121(6): 2586-2587
Malatesta, M.L.; Heath, H.E.; LeBlanc, P.A.; Sloan, G.L. 1992: EGTA inhibition of DNase activity in commercial lysostaphin preparations Biotechniques 12(1): 70; 72
Barbe, D.; Bauduer, F.; Tanguy, A. 1991: Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100 Annales de Biologie Clinique 49(10): 507-513
Navarro, M.A.; Raei, N.; Torres, F.; Granero, L.; García-Zaragoza, E.; Esplugues, J.V.; Esteban Peris, J. 1998: Differences in the release of omeprazole in 4 commercial preparations: influence of pH and ionic concentration Gastroenterologia y Hepatologia 21(2): 63-70
Viazov, S.O.; Doroshenko, N.V.; Khatkevich, S.P.; Reznikov, I.P.; Minakova, L.V. 1983: Antibodies to hepatitis a and B viral antigens in commercial gamma-globulin preparations Voprosy Virusologii 28(5): 542-545
López Fernández, M.F.; López Borrasca, A.; López Berges, C.; Batlle Fonrodona, J. 1985: Thrombin-mediated interaction between platelets and FvW present in commercial preparations and cryoprecipitate Sangre 30(5): 871-879
Grosshans, E.; Samsoen, M. 1981: Topical preparations combining a dermocorticoid and an antifungal agent and their commercial relevance Annales de Dermatologie et de Venereologie 108(5): 481-482
Migunov, V.N.; Pozina, I.M.; Maksimova, Z.I.; Chernobel', T.P.; Shinkarenko, A.I. 1985: Effect of the stage of isoelectric sedimentation on the quality of commercial preparations of gamma globulin Gematologiia i Transfuziologiia 30(10): 48-51
Hagemann, P. 1978: In vitro active ingredient liberation of five commercial prednisolone preparations in tablet form Pharmaceutica Acta Helvetiae 53(5): 133-135